Search Within

Kim Kramer

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (6)
  3. Editorial (1)
Groups
  1. Epidemiology and Biostatistics (33)
  2. Neuro-Oncology Service (33)
  3. Pediatrics, Department of (33)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (31)
  5. GSK Faculty (31)
  6. Tow Center for Developmental Oncology (TCDO) (31)

More Groups

People
  1. Nai-Kong Cheung (29)
  2. Brian Kushner (28)
  3. Shakeel Modak (18)
  4. Glenn Heller (10)
  5. Irene Cheung (9)
  6. Ellen Basu (8)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2022 (3)
  4. 2021 (2)
  5. 2019 (2)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Pediatric Blood and Cancer (5)
  3. Cancer (4)
  4. Neuro-Oncology (3)
  5. OncoImmunology (3)
  6. Medical and Pediatric Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. Wiley Periodicals, Inc (5)
  3. Wiley Blackwell (4)
  4. Landes Bioscience (3)
  5. Oxford University Press (3)
  6. Wiley Liss (2)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
    Journal Article

    Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin
    Journal Article

    Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Modak, S.; Kramer, K.; Roberts, S. S.; Basu, E. M.; Yataghene, K.; Cheung, N. K. V.
    Oncotarget (2016)

    Fulltext@MSK | Save
  • Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: A prospective phase II study
    Journal Article

    Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Kramer, K.; Modak, S.; Yataghene, K.; Cheung, N. K. V.
    OncoImmunology (2015)

    Fulltext@MSK | Save
  • Osteochondroma in long-term survivors of high-risk neuroblastoma
    Journal Article

    Kushner, B. H.; Roberts, S. S.; Friedman, D. N.; Kuk, D.; Ostrovnaya, I.; Modak, S.; Kramer, K.; Basu, E. M.; Cheung, N. K. V.
    Cancer (2015)

    Fulltext@MSK | Save
  • When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?
    Journal Article

    Cheung, N. K. V.; Modak, S.; Ostrovnaya, I.; Roberts, S. S.; Basu, E. M.; Kramer, K.; Kushner, B. H.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Key role for myeloid cells: Phase II results of anti-GD2 antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma
    Journal Article

    Cheung, N. K. V.; Cheung, I. Y.; Kramer, K.; Modak, S.; Kuk, D.; Pandit-Taskar, N.; Chamberlain, E.; Ostrovnaya, I.; Kushner, B. H.
    International Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma
    Journal Article

    Modak, S.; Kushner, B. H.; Kramer, K.; Vickers, A.; Cheung, I. Y.; Cheung, N. K. V.
    OncoImmunology (2013)

    Fulltext@MSK | Save
  • Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte- macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission
    Journal Article

    Cheung, N. K. V.; Cheung, I. Y.; Kushner, B. H.; Ostrovnaya, I.; Chamberlain, E.; Kramer, K.; Modak, S.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Qin, L. X.; Cheung, N. K. V.
    Cancer (2010)

    Fulltext@MSK | Save
  • Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastoma
    Journal Article

    Bhandari, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Modak, S.; Larson, S. M.; Yeh, S.; Heller, G.; Sklar, C. A.
    Pediatric Blood and Cancer (2010)

    Fulltext@MSK | Save